Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive chronic disorder characterized by activation of fibroblasts and overproduction of extracellular matrix (ECM). Caveolin-1 (cav-1), a principal component of caveolae, has been implicated in the regulation of numerous signaling pathways and biological processes. We observed marked reduction of cav-1 expression in lung tissues and in primary pulmonary fibroblasts from IPF patients compared with controls. We also demonstrated that cav-1 markedly ameliorated bleomycin (BLM)-induced pulmonary fibrosis, as indicated by histological analysis, hydroxyproline content, and immunoblot analysis. Additionally, transforming growth factor β1 (TGF-β1), the well-known profibrotic cytokine, decreased cav-1 expression in human pulmonary fibroblasts. cav-1 was able to suppress TGF-β1–induced ECM production in cultured fibroblasts through the regulation of the c-Jun N-terminal kinase (JNK) pathway. Interestingly, highly activated JNK was detected in IPF- and BLM-instilled lung tissue samples, which was dramatically suppressed by ad–cav-1 infection. Moreover, JNK1-null fibroblasts showed reduced smad signaling cascades, mimicking the effects of cav-1. This study indicates a pivotal role for cav-1 in ECM regulation and suggests a novel therapeutic target for patients with pulmonary fibrosis.

[1]  A. Choi,et al.  Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway. , 2006, American journal of respiratory cell and molecular biology.

[2]  Naftali Kaminski,et al.  Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. , 2006, American journal of respiratory and critical care medicine.

[3]  Naftali Kaminski,et al.  Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis , 2005, PLoS medicine.

[4]  P. Tsao,et al.  Transforming growth factor-β receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells , 2005 .

[5]  S. Sone,et al.  Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. , 2005, American journal of respiratory and critical care medicine.

[6]  S. Hoffman,et al.  Opposing Effects of Protein Kinase Cα and Protein Kinase Cϵ on Collagen Expression by Human Lung Fibroblasts Are Mediated via MEK/ERK and Caveolin-1 Signaling* , 2005, Journal of Biological Chemistry.

[7]  S. Hoffman,et al.  Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. , 2005, The Journal of biological chemistry.

[8]  A. Choi,et al.  Carbon monoxide suppresses bleomycin-induced lung fibrosis. , 2005, The American journal of pathology.

[9]  P. Tsao,et al.  Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells. , 2005, The Biochemical journal.

[10]  G. Raghu,et al.  Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects. , 2004, Clinics in chest medicine.

[11]  S. Maruyama,et al.  Caveolin-1 in mesangial cells suppresses MAP kinase activation and cell proliferation induced by bFGF and PDGF. , 2004, Kidney international.

[12]  Simon C Watkins,et al.  Redistribution of pulmonary EC-SOD after exposure to asbestos. , 2004, Journal of applied physiology.

[13]  D. Shegogue,et al.  Lysophosphatidic acid inhibits TGF-beta-mediated stimulation of type I collagen mRNA stability via an ERK-dependent pathway in dermal fibroblasts. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[14]  A. Mauviel,et al.  TGF-β-induced SMAD signaling and gene regulation : consequences for extracellular matrix remodeling and wound healing , 2004 .

[15]  N. Khalil,et al.  Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment , 2004, Canadian Medical Association Journal.

[16]  M. Kasper,et al.  A new rat type I-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression , 2004, Histochemistry and Cell Biology.

[17]  A. Mauviel,et al.  TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. , 2004, Journal of dermatological science.

[18]  M. Kasper,et al.  Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-β1 , 2004, Histochemistry and Cell Biology.

[19]  J. Enghild,et al.  Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. , 2003, Free radical biology & medicine.

[20]  S. Park,et al.  Senescent Phenotype Can Be Reversed by Reduction of Caveolin Status* , 2003, Journal of Biological Chemistry.

[21]  S. Jimenez,et al.  Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts. , 2003, American journal of respiratory cell and molecular biology.

[22]  Nir Friedman,et al.  Practical approaches to analyzing results of microarray experiments. , 2002, American journal of respiratory cell and molecular biology.

[23]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[24]  M. Spiteri,et al.  Growth factors in idiopathic pulmonary fibrosis: relative roles , 2001, Respiratory research.

[25]  M. Selman,et al.  Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder , 2001, Respiratory research.

[26]  M. Drab,et al.  Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice , 2001, Science.

[27]  M. Bitzer,et al.  Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.

[28]  M. Bitzer,et al.  Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. , 2001, The Journal of biological chemistry.

[29]  Mary E. Choi.  Mechanism of transforming growth factor-β1 signaling: Role of the mitogen-activated protein kinase , 2000 .

[30]  M. E. Choi.  Mechanism of transforming growth factor-beta1 signaling:. , 2000, Kidney international. Supplement.

[31]  J. Lasky,et al.  Interstitial fibrosis and growth factors. , 2000, Environmental health perspectives.

[32]  T. Godfrey,et al.  Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. , 2000, The Journal of molecular diagnostics : JMD.

[33]  Arnold Simanowitz,et al.  international consensus statement , 2000 .

[34]  K. M. Mulder,et al.  Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. , 2000, Methods in molecular biology.

[35]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[36]  P. Rakic,et al.  The Jnk1 and Jnk2 Protein Kinases Are Required for Regional Specific Apoptosis during Early Brain Development , 1999, Neuron.

[37]  G. Raghu,et al.  Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent , Pirfenidone Results of a Prospective , Open-label Phase II Study , 1999 .

[38]  P. Howe,et al.  TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway , 1999, The EMBO journal.

[39]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[40]  M. Lisanti,et al.  Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[41]  V. Dimmer,et al.  Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis , 1997, Histochemistry and Cell Biology.

[42]  E. V. van Donselaar,et al.  Cell-type and Tissue-specific Expression of Caveolin-2 , 1997, The Journal of Biological Chemistry.

[43]  K. Csaky,et al.  Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.

[44]  Y. Atoji,et al.  Structure of the perilobular sheath of the deep proventricular gland of the chicken: presence and possible role of myofibroblasts , 1996, Cell and Tissue Research.

[45]  Richard G. W. Anderson,et al.  Localization of Epidermal Growth Factor-stimulated Ras/Raf-1 Interaction to Caveolae Membrane (*) , 1996, The Journal of Biological Chemistry.

[46]  Richard G. W. Anderson,et al.  Localization of Platelet-derived Growth Factor-stimulated Phosphorylation Cascade to Caveolae (*) , 1996, The Journal of Biological Chemistry.

[47]  H. Lodish,et al.  Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in Muscle (*) , 1996, The Journal of Biological Chemistry.

[48]  R. G. Anderson,et al.  Caveolae: where incoming and outgoing messengers meet. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Richard G. W. Anderson,et al.  Caveolin, a protein component of caveolae membrane coats , 1992, Cell.

[50]  Malhotra Sk,et al.  The plasma membrane , 1988 .